BIRMINGHAM, UK — Modified-release (MR) metformin and an SGLT2 inhibitor (SGLT2i) should be the first line of treatment for most people with type 2 diabetes according to revised guidance from the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results